Histological Hallmarks of Mucosal Healing in Inflammatory Bowel Diseases in the Era of Monoclonal Antibodies Therapy: New Insights and Perspectives

Background: Chronic inflammatory bowel diseases (IBDs) are gaining increasing attention, both because they can severely reduce the quantity and quality of life, and because the advent of monoclonal antibodies has profoundly changed the natural history of these diseases. In recent years, the concept...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Gerardo Cazzato, Anna Colagrande, Valeria Andriola, Teresa Lettini, Sebastiano Cicco, Pragnell Mary Victoria Candance, Leonardo Resta, Leonardo Vincenti, Giuseppe Ingravallo
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-08-01
Saila:	Diagnostics
Gaiak:	IBD biological infliximab adalimumab vedolizumab histology
Sarrera elektronikoa:	https://www.mdpi.com/2075-4418/11/9/1570
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!